Intervention of a Health Education Clinical Nursing Pathway Among Patients with Ovarian Carcinoma

2021 Year in Review - Ovarian Cancer —March 21, 2022

Categories:

Ovarian Cancer

Results from a retrospective analysis indicate that health education, using a clinical nursing pathway, results in a more effective understanding of ovarian cancer, reduced psychological burden, improved sleep quality, decreased incidence of complications, improved self-care agency, and improved quality of life among patients with ovarian cancer.

A retrospective study investigated the effect of health education on several parameters, including self-care agency, quality of life, negative emotions, and nursing satisfaction among patients with ovarian carcinoma. Results of this analysis were published in the American Journal of Translational Research.

The study identified patients with stage I or II ovarian carcinoma, aged between 30 and 60 years, treated at a hospital in China from January 2019 to January 2020; the clinical data for these patients were analyzed. Patients were classified into 2 groups: a control group that received health education per routine nursing, and an observation group that received the intervention via a specified clinical nursing pathway. Several parameters were analyzed between the 2 groups before and after the intervention, including postoperative complications such as deep vein thrombosis; self-care agency score; quality-of-life score, as evaluated by the Quality-of-Life Questionnaire-30; and health knowledge, as assessed by an ovarian carcinoma knowledge questionnaire. Sleep quality, as evaluated by the Pittsburgh Sleep Quality Index; negative emotions, as assessed by the Hamilton Anxiety Scale and Hamilton Depression Scale; and nursing satisfaction were also assessed.

A total of 61 patients were included in the study; 31 patients were included in the control group and 30 patients in the observation group. Following the health education intervention, patients in the observation group showed significantly higher levels of health knowledge and lower incidence of postoperative complications than those in the control group. The scores of negative emotions and sleep quality were significantly decreased in both groups after intervention compared with those before intervention (P <.05), and scores in the observation group were significantly lower than those in the control group (P <.05). Similarly, scores of self-care agency and quality of life were significantly higher after intervention than before intervention (P <.05); moreover, patients in the observation group showed higher scores than those in the control group (P <.05). Patients indicated that overall nursing satisfaction was relatively high.

Based on these results, the investigators concluded that health education intervention via a clinical nursing pathway can yield a more effective understanding of ovarian cancer, reduced psychological burden, improved sleep quality, decreased incidence of complications, improved self-care agency, and improved quality of life among patients with ovarian cancer.

Source: Zhao J, Chai G, Yang F, et al. Analysis of the change of clinical nursing pathway in health education among patients with ovarian carcinoma. Am J Transl Res. 2021;13:3138-3146.

Related Articles
How to Sequence Treatment in Relapsed Ovarian Cancer
2021 Year in Review - Ovarian Cancer
This review outlines treatment sequencing considerations for patients with recurrent ovarian cancer.
Maintenance Gemogenovatucel-T Immunotherapy in Newly Diagnosed Advanced Ovarian Cancer
2021 Year in Review - Ovarian Cancer
Results of the phase 2b VITAL trial suggest that immunotherapy with the autologous tumor cell vaccine gemogenovatucel-T as frontline maintenance in stage III/IV ovarian cancer is well-tolerated and shows clinical benefit in both BRCA-wild type and homologous recombination–proficient subgroups.
Patient Self-Reporting of Tolerability in Phase 2 Trial Comparing Gemcitabine plus Adavosertib or Placebo in Women with Platinum-Resistant Epithelial Ovarian Cancer
2021 Year in Review - Ovarian Cancer
Patient-reported outcomes of tolerability with adavosertib indicated greater incidence of fatigue, diarrhea, mucositis, and difficulty swallowing in patients receiving adavosertib and gemcitabine; however, no significant differences were noted in the symptomatic adverse-event profile for gastrointestinal events and anxiety.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country